Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. About MyMD Pharmaceuticals, Inc.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

DECEMBER 23, 2021

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. billion by 2025. Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. However, regulations are constantly shifting.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

NOVEMBER 16, 2021

As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-? About MYMD-1.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

SMPL

MAY 26, 2020

For years, he’d been determined to connect the nascent CBD research he heard about at symposiums abroad with the medical marijuana movement in California. CBD industry will be worth $16 billion by 2025. This makes further research very difficult to do, and causes sick people in many states to be treated as criminals.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Puff Puff Post

DECEMBER 28, 2018

Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. This is on par with the cost currently seen for those afflicted with ADHD and diabetes, with predictions for the cost to skyrocket further by 2025.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JULY 15, 2022

Last week, federal Health Minister Greg Hunt announced changes to regulations that would allow for medicinal cannabis exports, capitalising on what the Government estimated would be a $70 billion industry by 2025. I know that Medifarm was the first fully licensed, so cultivation and manufacturing and research licensed company in Australia.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

OCTOBER 17, 2019

Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40